baber/WOPTO huggingface dataset:
Patent CA-2454744-A1 (CA)
Title: Device for producing preforms in batch quantities
Inventor: WEINMANN ROBERT
IPC: B29C35/16
Filed: 2002-07-26
Abstract: The invention relates to the production of preforms (10) for PET bottles in batch quantities. According to the invention, the mould nests are arranged i n the injection moulds in a specific manner, thereby increasing the number of cooling positions in an after cooler (19, 40). The inventive device is provided with controllable/adjustable movement means for the two coordinates (x, y; y, z) of the transfer plane of the after cooler (19, 40), enabling th e after cooler (19, 40) to be cyclically positioned with respectively free cooling positions in the fixed arrangement of moulded objects (10) in the moulds, whereby a maximum density of cooling positions can be obtained in sa id after cooler (19, 40) . The invention enables four times more cooling positions to be obtained, especially when arranged in a staggered manner, in comparison with the number of mould nests in said mould, in addition to allowing the number of mould nests to be increased to 144 and more.
Patent CA-2456645-A1 (CA)
Title: Composition and container for treating a vertical surface
Inventor: KANDASAMY MANIVANNAN
IPC: A47L23/05
Filed: 2002-09-13
Abstract: An improved container contains a housing containing at least one aperture an d a treatment composition located within the housing. The combination of the treatment composition and the housing has a mess factor of from about 3.6 * 10- 4 to about 1.1 * 10-11. When the housing is in a prepared state and squeezed , the treatment composition exits the housing from the aperture.
Patent CA-2459763-A1 (CA)
Title: Method of manufacturing optical devices and related improvements
Inventor: LIU XUE FENG
IPC: H01L21/18
Filed: 2002-07-30
Abstract: There is disclosed an improved method of manufacturing an optical device using an impurity induced Quantum Well Intermixing (QWI) process. Reported QWI  methods, and particularly Impurity Free Vacancy Diffusion (IFVD) methods, suffer from a number of disadvantages, eg the temperature at which Gallium Arsenide (GaAs) out-diffuses from the semiconductor material to the Silica (SiO2) film. Accordingly, the present invention provides a method of manufacturing an optical device, a device body portion (5a) from which the device is to be made including at least one Quantum Well (QW) (10a), the method including the steps of: causing an impurity material to intermix with the at least one Quantum Well (QW) (10a), wherein the impurity material at least includes Copper (Cu).
Patent CA-2459779-A1 (CA)
Inventor: HENDRICKS JOHN S
IPC: H04N21/6334
Filed: 1994-12-02
Abstract: The invention, an electronic book selection and delivery system, distributes text to subscribers. The system includes a subsystem for placing text in a video signal format and a subsystem for receiving and selecting video format text. The system contains an operations center, a video distribution system, a home subsystem, and a billing and collection system. The operation center and/or video distribution points perform the functions of manipulation of text data, security and coding of text, cataloging of books, message center, and uplink functions. The home subsystem connects to a video distribution system, generates menus and stores text, and transacts through communicating mechanisms. A portable book-shaped viewing device is used for viewing the text. The billing system performs the transaction, management, authorization, collection and payments utilizing the telephone system.
Patent CA-2462224-A1 (CA)
Title: Method and apparatus for recording a digital information signal
Inventor: DE HAAN WIEBE
IPC: H04N9/82
Filed: 2002-09-18
Abstract: Method of contiguously recording a sequence of ordered A/V information signals, such as video/audio information, and corresponding management information signals, such as video management, menu information or file information, on a disc-like recording medium of the write-once type, such as an optically recordable and readable disc. The recorded information complies to the requirements of ordering of such information as defined by a disc of the read-only type or of the rewritable type. The method comprises allocatin g a reserved area within a linear addressing space of the disc, contiguously recording the A/V information signals in a video recording area located succeeding the reserved area, recording corresponding management data in a temporary overview space succeeding the video recording area, generating a mapping table for mapping the recorded management data to address locations in the reserved area and recording the mapping table in the temporary overview space. When finalizing the disc, the recorded management information signals is copied to the reserved area in correspondence to the latest mapping table information and the remaining unrecorded sections of the reserved area is recorded with arbitrary data signals.
Patent CA-2463881-A1 (CA)
Inventor: INCH PETER
IPC: B29C48/09
Filed: 2002-10-24
Abstract: L'invention porte sur un procédé de recyclage de tapis pour en former des articles, et sur les articles ainsi formés. Dans une exécution, le procédé comporte les étapes suivantes: fusion des tapis à recycler; réduction de leur teneur en eau à moins de 0,5 % du poids total tapis + eau; formation d'un ruban fondu; et formation de grains à partir du ruban extrudé de matériau recyclé.
Patent CA-2464492-A1 (CA)
Title: Device and method for labeling objects
Inventor: PFERRER MARKUS
IPC: B41J29/393
Filed: 2003-06-03
Abstract: The invention relates to a device and a method for labelling objects, in particular food packages. The device comprises a printer, in particular a thermal--direct printer or thermal-transfer printer for printing labels; an application device for applying a printed label to the object to be labelled; and at least one working device, arranged upstream of the application device, in the form of a weighing device, a packaging device, and/or a transport device for the objects to be labelled. In order to prolong the service life of the print head and to improve the print quality, the provision of a measuring and control device is proposed which for each object to be labelled determines the printing time that is available for printing the label to be applied to each of said objects, taking into account the required working time of the working device/s, and which measuring and control device, depending on the printing time determined, controls the printer such that printing of the label is completed within the available printing time at a matching printing speed, which is as slow as possible.
Patent CA-2466620-A1 (CA)
Inventor: KRUMBHOLZ KLAUS
IPC: A61K6/027
Filed: 2003-06-24
Abstract: The invention relates to an opalescent glass-ceramic product, especially an opalescent glass-ceramic product as a dental material or as an additive to or component of dental material, comprising at least the components SiO2, Al2O3, P2O5, Na2O, K2O, CaO and Me(IV)O2. In order to obtain improved opalescence with improved transparency, in addition to fluorescence, thermal expansion and a combustion temperature adapted to other materials, the opalescent ceramic product is devoid of ZrO2 and TiO2or is essentially devoid of ZrO2 and TiO2, such that the Me(II)O content in the glass ceramic is less than approximately 4 wt. % and the Me(IV)O2 content amounts to approximately 0.5 - 3 wt. %. The invention also relates to a method for the production of the opalescent glass-ceramic product. The glass-ceramic product can be used as dental material or as an additive to or a component of dental material.
Patent CA-2466966-A1 (CA)
Title: Bags
Inventor: WITHERS PHILIP CRAIG
IPC: B65D33/00
Filed: 2002-11-14
Abstract: Disclosed is a bag (11), and a method of making the bag, having a welded end (12) and an open end (13) having a series of flaps or tie parts (14) formed thereon. The bag is formed from a tubular body folded upon itself along its longitudinal central region whereby no more than two gussets are formed alon g each longitudinal edge of the bag. A roll (10) of bags (11) is also disclose d in which the welded end (12) of one bag is joined by a line of weakness (15) to the flap or tie parts (14) of the next bag in the roll.
Patent CA-2468780-A1 (CA)
Title: Dispositif medical resistant aux microbes, revetement resistant aux microbes et procedes permettant de les produire
Inventor: TERRY RICHARD N
IPC: A61L29/16
Filed: 2002-12-03
Abstract: L'invention concerne des dispositifs médicaux résistants aux microbes et des procédés permettant de les produire. Une couche de base est appliquée sur au moins une partie d'une surface dudit dispositif. Cette couche de base comprend au moins un type de particules antimicrobiennes, retenues dans la couche de base. Une couche supérieure polymère est appliquée sur au moins une partie de la couche de base. La couche supérieure peut être un polymère organique soluble, un polymère hydrosoluble, un hydrogel ou tout autre polymère apte à être appliqué sur un dispositif médical. Le polymère de la couche supérieure est soluble dans un solvant qui ne dissout pas la couche de base polymère pendant l'application de la couche supérieure. Ladite couche supérieure demeure exempte de particules antimicrobiennes par non dissolution de la couche de base pendant le processus d'application de la couche supérieure.
Patent CA-2469380-A1 (CA)
Title: Heteroaryl-substituted aminocyclohexane derivatives
Inventor: ACKERMANN JEAN
IPC: C07D409/04
Filed: 2002-12-11
Abstract: The present invention relates to compounds of formula (I) wherein A1, A2, A3, A4, A5, A6, U, V, m, n and o are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualenelanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasit infections, gallstones, tumors and/or hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.
Patent CA-2470096-A1 (CA)
Title: Counterfeit detection system and computerized monetary system
Inventor: ONISCHUK DANIEL W
IPC: G07D7/004
Filed: 2004-06-07
Abstract: A national computer system, is used to track currency to reduce losses of currency fraud. A unique identifier ( Currency Identifier or CID ) is assigned to each item of monetary currency. The CID is used to authenticate the currency item is valid currency for use.  As counterfeit CID are detected, they are added to a nationally shared computer database, enabling anyone to also compare a CID to all of the already known counterfeited currency CID's. The CID is further used to identify the location of the currency item. By identifying the location where the request for authentication occurred, any subsequent request for the same CID is assessed by people or computers executing tracking and assessment software programs. The CID requester is compared to other recent requests for the same CID. If the time and physical distance between locations are reasonable as per computer program models and data, then no action is taken; however, if a CID is reported at nearly the same time in distant places, or outside a reasonable transportation time limit for the last known reported location of the currency, then an alert message is sent to the requester indicating the bill may be counterfeit, so that the requester can more closely inspect the currency.
Patent CA-2471461-A1 (CA)
Title: Pyrrolidine-2-ones as factor xa inhibitors
Inventor: YOUNG ROBERT JOHN
IPC: A61K31/546
Filed: 2002-12-20
Abstract: The invention relates to compounds of formula (I): , and pharmaceutically acceptable derivatives thereof. The invention also relates to processes for the preparation of compounds of formula (I), pharmaceutical compositions containing compounds of formula (I) and to the use of compounds of formula (I) in medicine, particularly in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
Patent CA-2471794-A1 (CA)
Inventor: NAVAS RAMIREZ JOSE CARLOS
IPC: A61K31/192
Filed: 2002-12-06
Abstract: The present invention relates to the use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid, respectively, for the treatment or prevention of mild cognitive impairment (MCI) in mammals, especially in human beings.  Futhermore, the present invention also concerns the use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid, respectively, for delaying or preventing the conversion of MCI into dementia, especially Alzheimer's Disease.
Patent CA-2476755-A1 (CA)
Inventor: HOSKEN NANCY ANN
IPC: C12N1/21
Filed: 2002-12-16
Abstract: L'invention concerne des compositions et des procédés applicables à la thérapie et au diagnostic pour la maladie intestinale inflammatoire, y compris la maladie de Crohn et la colite ulcéreuse. Par exemple, l'invention concerne des compositions qui renferment un ou plusieurs polypeptides bactériens, des parties immunogènes correspondantes, des polynucléotides codant ces polypeptides, et des lymphocytes T spécifiques aux cellules exprimant les polypeptides en question. Les compositions décrites sont utiles, par exemple, pour le diagnostic, la prévention et/ou le traitement de la maladie intestinale inflammatoire.
Patent CA-2477135-A1 (CA)
Inventor: CRIVELLO JAMES V
IPC: C08F2/46
Filed: 2003-03-10
Abstract: L'invention concerne des compositions pouvant être photopolymérisées par un amorceur cationique, à grande vitesse. Ces compositions renferment au moins un monomère époxyde, au moins un photoamorceur cationique, et un photosensibilisant/accélérateur. L'accélérateur est un résol phénolique ou un composé possédant une structure représentée par la formule générale R?1¿(CR?2¿R?3¿OH)¿n?, dans laquelle R?1¿ désigne un élément sélectionné dans le groupe comprenant un phényle, un aryle polycyclique et un hétéroaryle polycyclique, tous éventuellement substitués par un ou plusieurs phényles substitués par un groupe donneur d'électrons ; R?2¿ et R?3¿ désignent des éléments sélectionnés indépendamment dans le groupe comprenant un hydrogène, un alkyle, un aryle, un alkylaryle, un alkyle substitué, un aryle substitué et un alkylaryle substitué ; et n désigne un entier compris entre 1 et 10.
Patent CA-2477651-A1 (CA)
Title: Kinase inhibitors
Inventor: BURCHAT ANDREW
IPC: A61P11/06
Filed: 2003-03-21
Abstract: The present application is directed to pyrazolopyrimidine and furopyrimidine analogs of the formula (I), wherein the substituents are as defined herein, which are useful as kinase inhibitors.
Patent CA-2478778-A1 (CA)
Inventor: COMBS GEORGE G
IPC: C08G18/48
Filed: 2004-08-23
Abstract: The present invention provides a crystalline, hydroxide containing double metal cyanide (DMC) catalyst of the formulae (I) or (II), M1x[M2(CN)6]y OH .cndot. L ~~(I) M1x[M2(CN)6]y~zM1(OH)q.cndot. L         (II) wherein M1 represents a metal selected from Zn+2, Fe+2, Ni+2, Mn+2, Co+2, Sn+2, Pb+2, Fe+3, Mo+4, Mo+6, Al+3, V+4, V+5, Sr+2, W+4, W+6, Cu+2 and Cr+3, M2represents a metal selected from Fe+2, Fe+3, Co+2, Co+3, Cr+2, Cr+3, Mn+2, Mn+3, Ir+3, Ni+2, Rh+3, Ru+2, V+4 and V+5, L represents an organic ligand and x, y and q are chosen to maintain electroneutrality. Further provided are processes for the production of the inventive DMC catalysts.      The crystalline, hydroxide containing DMC catalysts of the present invention may find use in in the preparation of polyols, such as polyether polyols.
Patent CA-2478781-A1 (CA)
Title: Convergent-divergent nozzle for jet turbine engine
Inventor: FEDER DIDIER
IPC: F02K1/82
Filed: 2004-08-10
Abstract: The nozzle (1) has follow-up divergent flaps (4b) interposed between control flaps and having a structure in box with internal and external radial walls. The divergent flaps provide lateral openings to deliver cooling air in direction of an internal side of control divergent flaps (4a) for cooling them. The radial walls are inserted into each other at level of their lateral ends for sliding with respect to each other.
Patent CA-2479041-A1 (CA)
Title: Technique for blood pressure regulation
Inventor: SHALEV ALON
IPC: A61N1/36
Filed: 2003-03-13
Abstract: An implantable device (20) uses the carotid baroreflex in order to control systemic blood pressure. The implant includes sampling and pulse stimulation electrodes (44) preferably located on the carotid sinus nerve branch of the glossopharyngeal nerve, adjacent and distal to the carotid sinus baroreceptors. The stimulators have an external control unit, which communicates with the implant for determining appropriate operational parameters, and for retrieving telemetry information from the device's data bank. Typically two internal devices are implanted, one at each side of the patient's neck.
Patent CA-2479814-A1 (CA)
Inventor: KUEHFUSZ RUDOLF
IPC: B29C37/00
Filed: 2003-03-20
Abstract: Fiber-reinforced structural parts are coated to refine and color the surface s especially if they are used as body parts in the automotive industry. According to the invention, a plastic film that already has the desired properties regarding the structure and optionally the color of the surface o f the structural part and that is already preformed corresponding to the topography of the surface of the structural part is inserted in a corresponding mold. A fiber-reinforced plastic, preferably comprising a duroplastic or thermoplastic matrix, is applied to the side of the preformed film that is not the surface by means of a method adapted to the composition of the semi-finished product and the finished structural part is withdrawn from the mold once the fiber-reinforced plastic has been pressed and hardene d or cooled off.
Patent CA-2480777-A1 (CA)
Title: Procedes d'utilisation des antagonistes des cytokines dans le traitement de l'infection par le vih et le sida
Inventor: STAHL NEIL
IPC: A61K39/395
Filed: 2003-05-01
Abstract: L'invention porte sur des procédés d'utilisation des antagonistes des cytokines pour traiter le VIH, et notamment sur des méthodes de traitement du VIH en utilisant des antagonistes des cytokines IL-4 et IL-13, y compris des pièges à cytokines et des anticorps contre IL4 ou contre IL-13. L'invention porte également sur l'accroissement de l'efficacité de la vaccination contre le VIH par co-administration du vaccin avec des antagonistes des cytokines IL-4 et IL-13.
Patent CA-2481187-A1 (CA)
Inventor: JINKS PHILIP A
IPC: A61K31/167
Filed: 2003-04-01
Abstract: L'invention concerne une formulation d'aérosol pharmaceutique comprenant des particules de formoterol ou un sel pharmaceutiquement acceptable de celui-ci, un solvate ou un dérivé physiologiquement fonctionnel de celui-ci, lesdites particules étant en suspension dans la formulation. L'invention concerne un composé de formule (I), dans laquelle R¿1?représente 1-butyle, 2-butyle, cyclohéxyle ou phényle et R¿2 ?représente acétyle ou isobutanoyle, ledit composé de formule (I) étant dissous dans la formulation; et un propulseur sélectionné parmi 1,1,1,2-tétrafluoroéthanne, 1,1,1,2,3,3,3-heptafluoropropane et un mélange de ceux-ci.
Patent CA-2481767-A1 (CA)
Inventor: KITAZAKI TOMOYUKI
IPC: A61P31/10
Filed: 2003-04-07
Abstract: L'invention concerne un agent thérapeutique pour la prévention d'état septique grave, qui renferme un composé représenté par la formule générale (I) ou (II), y compris un sel ou un promédicament correspondant. L'invention concerne également un inhibiteur de signal de récepteur Toll (TLR) qui renferme un composé non peptidique et un agent thérapeutique pour la prévention de dérèglement d'organe, entre autres, qui renferme un matériau inhibiteur de signal de récepteur TLR.
Patent CA-2483507-A1 (CA)
Title: Enzyme et marqueur snp pour le depistage d'une maladie
Inventor: COOKSON WILLIAM OSMOND CHARLES
IPC: A61K31/7088
Filed: 2002-04-24
Abstract: La présente invention concerne une séquence nucléotidique isolée qui code une nouvelle protéine, cette protéine constituant un nouveau membre de la famille des enzymes ayant une activité de peptidase. L'invention concerne également l'utilisation de la séquence nucléotidique et/ou de la protéine dans la médecine et dans la recherche, un procédé permettant de diagnostiquer une maladie ou de déterminer une prédisposition à cette maladie, des procédés de prévention ou de traitement de cette maladie, ainsi que des trousses à utiliser pour la mise en oeuvre de ces procédés et l'utilisation de la séquence nucléotidique, de la protéine et d'inhibiteurs de celle-ci dans le traitement ou la prévention de maladies inflammatoires et dans des cribles utilisés pour l'identification de nouveaux inhibiteurs. L'invention concerne également des vecteurs d'expression de l'acide nucléique, des cellules hôtes, des cribles et des animaux transgéniques non humains.
Patent CA-2485365-A1 (CA)
Title: Ctp-extended erythropoietin
Inventor: FARES FAUD
IPC: C07K14/505
Filed: 2003-05-13
Abstract: Erythropoietin containing a CTP extension and secreted from CHO cells exhibits a favorably extended biological half-life.
Patent CA-2486832-A1 (CA)
Inventor: MAY JESSE A
IPC: A61K31/4162
Filed: 2002-12-11
Abstract: L'invention concerne des pyranoindazoles, des procédés permettant d'abaisser et de réguler une pression intraoculaire normale ou élevée, et une méthode de traitement du glaucome à l'aide de compositions renfermant un ou plusieurs composés selon l'invention.
Patent CA-2489605-A1 (CA)
Title: Oxaliplatin anti-resistance agent
Inventor: PAU BERNARD
IPC: C12N5/09
Filed: 2003-06-17
Abstract: An in vitro method for detecting resistance of cancer cells (CC) to treatment with oxaliplatin (I) comprises measuring mitochondrial apoptosis of CC that have been, or could be, treated with (I), or before treatment, is new. Independent claims are also included for: (1) a similar method comprising detecting at least one mutation that indicates a defect in mitochondrial apoptosis when cells are treated with (I), particularly a mutation in a region of the Bax gene that contains a series of 8 deoxyguanines;  (2) method for selecting agents (II) that inhibit resistance of CC to (I);  (3) use of at least one agent (III) that stimulates mitochondrial apoptosis to prepare a composition for use in patients with (or at risk of developing) resistance to (I); (4) product/composition containing (I) and at least one (III);  (5) kit for diagnosing resistance of cancer to (I); and  (6) the cell HCT116/S, deposited as CNCM I-3051.
Patent CA-2491760-A1 (CA)
Inventor: LEWIN LAURA ANN
IPC: C08F8/30
Filed: 2003-07-11
Abstract: L'invention concerne des compositions de revêtement à deux composants qui durcissent dans des conditions ambiantes et plus particulièrement des compositions à faible teneur organique volatile, qui s'utilisent dans des applications de remise à neuf d'automobiles et de fabrication d'équipements automobiles. La composition de revêtement comprend des composants réticulables et réticulants, le composant réticulable comprenant un copolymère de faible polydispersité, de faible poids moléculaire, présentant une moyenne de 2 à 25 groupes fonctionnels, comme hydroxyle, carboxyle, acéto-acétoxy, amine primaire et secondaire et époxy. Le copolymère est polymérisé à partir d'un mélange monomère comprenant un ou plusieurs monomères acrylate non fonctionnels et un ou plusieurs monomères méthacrylate fonctionnels dotés des groupes fonctionnels. Le composant de réticulation comprend polyisocyanate, polyamine, cétimine, mélanine, époxy, polyacide ou une combinaison des différents constituants. L'invention concerne également des revêtements produits à l'aide de ladite composition de revêtement.